Jun 07, 2021 / 10:00PM GMT
Operator
Good afternoon. My name is Lara, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. Oncology Event at ASCO 2021 Webcast Conference Call. (Operator Instructions) I would now like to turn the call over to Peter Dannenbaum, Vice President, Investor Relations. Sir, the floor is yours.
Peter Dannenbaum - Merck & Co., Inc. - VP of IR
Thank you, Lara, and good evening, everyone. Welcome to Merck's 2021 ASCO Investor Call. Dr. Dean Li, President of Merck Research Labs, will lead off our presentation with an overview of our oncology program. He will be followed by Dr. Roy Baynes, Head of Global Clinical Development, who will provide Merck's ASCO data highlights; Dr. Vicki Goodman, Head of Late-stage Oncology Development; and Dr. Eric Rubin, Head of Early-stage Oncology Development, will provide insights into several of our development programs; Jannie Oosthuizen, Head of Oncology Human Health, will provide a commercial perspective; Frank Clyburn, President of Human Health, will be available for the Q&
Merck & Co Inc Oncology Event at ASCO Transcript
Jun 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers